Zhang Financial’s AstraZeneca AZN Stock Holding History

Zhang Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$430K	Hold	2,270	–	–	0.01%	283
2026 Q1	$448K	Buy	+2,270	New	+$438K	0.02%	258

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zhang Financial's AZN Position: Q2 2026 in Review

Zhang Financial held its AstraZeneca (AZN) position steady in Q2 2026 at 2,270 shares worth $430K. The position accounts for 0.01% of the portfolio, ranked #283.

Zhang Financial first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $448K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Zhang Financial held 2,270 shares of AstraZeneca worth $430K as of Q2 2026.
Zhang Financial left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Zhang Financial's portfolio in Q2 2026, its #283 holding.
Zhang Financial first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Zhang Financial's AstraZeneca position peaked at $448K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Zhang Financial's 13F filing for Q2 2026, filed 30 Jul 2026.